药价下降波及上市管理公司20个品种 整体影响有限（The decline in drug prices affects 20 listed management companies, with limited overall impact）.docVIP

药价下降波及上市管理公司20个品种 整体影响有限（The decline in drug prices affects 20 listed management companies, with limited overall impact） Author: Ruan Xiaoqin Since March this year, the national development and Reform Commission, the second year of drug price, namely since September 1st, hormone, regulating endocrine and nervous system drugs such as the average price dropped by about 14%. A drug company told reporters, perhaps there will be subsequent drug price adjustment policy. Drug price policy and the introduction of the national development and Reform Commission, involving a total of 82 species, more than 400 kinds of specifications, including the price range of single drug pricing and uniform pricing of drugs, also canceled some have stopped production or import drug pricing alone. Northeast Securities analyst Zhou Sili believes that this price is uniform pricing of drugs and drug pricing and price alone, the highest price drop, less price drop or not drop, the overall price is slightly less than expected, the domestic pharmaceutical enterprises by the impact of the smaller than expected. Among them, separate pricing varieties of drug price reduction involving a total of 36 varieties and 96 forms, mainly for foreign companies and joint ventures, but also relates to the part of the listed companies (listed company special: CRE securities analyst Liao Wanguo believes that the price of the special treatment of foreign investment will be gradually cancelled, this is a challenge for domestic pharmaceutical companies both opportunities: opportunities in foreign companies no longer have excess profits to support hundreds of abroad market activity cost; the challenge lies in the gap to narrow the retail price of the domestic pharmaceutical companies to gradually reduce the price advantage. Uniform pricing of drug price reduction involving varieties of 77 varieties, 363 kinds of specifications, the affected companies including pharmaceutical, Fosun Pharmaceutical, Xianju pharmaceutica